OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Immunology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection	279
An easy pill to swallow: oral recombinant vaccines for the 21st century	98
Mechanistic insights into epigenetic contributions to psoriasis pathogenesis and their clinical implications	93
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity	85
Principles and practical applications of structure-based vaccine design	74
Oncogenic viruses, cancer biology, and innate immunity	71
TAP-ing into the cross-presentation secrets of dendritic cells	68
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy	68
The future of vaccination in Latin America: learning from the COVID-19 pandemic	67
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation	60
Can juvenile idiopathic arthritis be cured?	60
Mycobacterial diseases in patients with inborn errors of immunity	60
Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs	57
Host genetics of innate immune system in infection	53
Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity	51
Safety switches for adoptive cell therapy	49
Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses	48
Innate antiviral immunity and immunometabolism in hepatocytes	46
Commander-in-chief: monocytes rally the troops for defense against aspergillosis	44
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules	44
Can we cure Behçet syndrome?	44
Complement in antiphospholipid syndrome, time to target?	42
Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models	42
B cell–targeted therapies in autoimmune skin disease: current advances and challenges	42
Can sarcoidosis be cured?	42

Regulation of MHC class II and CD86 expression by March-I in immunity and disease	41
Necroptosis in immunity, tissue homeostasis, and cancer	40
Nutritional modulation of antitumor immunity	40
Metabolism and macrophages in the tumor microenvironment	40
Mechanistic considerations linking SARS-CoV-2 infection, inflammation, and the loss of immune tolerance	39
Immunological lessons from genome-wide association studies of infections	39
Animal models of autoimmune encephalitis	38
Mapping and modelling human B cell maturation in the germinal centre	32
Can we cure bullous skin diseases?	32